COSENTYX (secukinumab) for the Ongoing Management of Adult Patients with Moderate to Severe Plaque Psoriasis and Active Psoriatic Arthritis

Summary: This Product Theater, sponsored by Novartis Pharmaceuticals, from the SDPA 14th Annual Fall Dermatology Conference 2016, held November 3 – 6 in Las Vegas, Nevada, titled “COSENTYX (secukinumab) for the Ongoing Management of Adult Patients with Moderate to Severe Plaque Psoriasis and Active Psoriatic Arthritis” was presented by Clive Liu, MD.